Related Experiment Video
Updated: Aug 11, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Biphasic effects of dithiocarbamates on the activity of nuclear factor-kappaB
1Yonsei Brain Research Institute and Department of Pharmacology, Yonsei University College of Medicine, Seoul, South Korea.
Abstract:
Dithiocarbamates are well-known antioxidants and nuclear factor-kappaB (NF-kappaB) inhibitors. Recently, they have been characterized as zinc ionophores. Concentration-dependent biphasic effects of dithiocarbamates on NF-kappaB activity have been widely reported. We studied the mechanism of this phenomenon in relation to Zn(2+) influx. Two dithiocarbamates, pyrrolidine dithiocarbamate and diethyldithiocarbamate, showed concentration-dependent biphasic effects in inhibiting NF-kappaB activation in cerebral endothelial cells. These unique effects of dithiocarbamates on NF-kappaB were tightly linked to their ability to elevate intracellular Zn(2+)500 microM), dithiocarbamates started to lose their ability to promote Zn(2+) influx and to inhibit NF-kappaB activation. These results might provide insight into the appropriate use of dithiocarbamates in various disorders.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Time Course of Drug Effect
Pharmacokinetics: Drug–Drug Interactions

